This description embodies the decades-old doctrine that CAFs, fibrosis and a wound repair response are uniformly tumour-promoting [9], and a multitude of studies have identified the contribution of CAFs to chemoresistance, immunosuppression and tumour progression [10,11,12]. The gene discussed is TBX1; the disease is neoplasm.